4[1]Pourshams A,Malekzadeh R,Monavvari A,et al.Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors[J].J Gastroenterol Hepatol,2005,20(2):229-233.
5[2]Liangpunsakul S,Chalasani N.Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome:results from the third National Health and Nutrition Survey (NHANES Ⅲ)[J].Am J Med Sci,2005,329(3):111-116.
6[3]Ioannou GN,Weiss NS,Boyko E J,et al.Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease[J].Gastroenterology,2005,128(3):627-635.
7[4]Kahn R,Buse J,Ferrannini E,et al.TThe metabolic syndrome:time for a critical appraisal:joint statement from the American Diabetes Association and the European Association for the Study of Diabetes[J].Diabetes Care,2005,28(9):2289-2304.
8[5]Pendino GM,Mariano A,Surace P,et al.Prevalence and etiology of altered liver tests:a population-based survey in a Mediterranean town[J].Hepatology,2005,41 (5):1151-1159.
9[6]Daniel S,Ben-Menachem T,Vasudevan G,et al.Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients[J].Am J Gastroenterol,1999,94(10):3010-3014.
10[7]Graif M,Yanuka M,Baraz M,et al.Quantitative estimation of attenuation in ultrasound video images:correlation with histology in diffuse liver disease[J].Invest Radiol,2000,35(5):319-324.
